Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Coya Therapeutics, Inc.COYA · Entity 6727 | Director | January 02, 2026 | January 07, 2026 |
| Replimune Group, Inc.REPL · Entity 4707 | Director | April 01, 2026 | April 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Coya Therapeutics, Inc.
Report date January 02, 2026 · Filed January 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.65 · Expires 2036-01-02 | Direct | 10,000 |
Reported balance
After 2026-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 10,000 · Balance 10,000 F1: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.
Replimune Group, Inc.
Report date April 01, 2026 · Filed April 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.61 · Expires 2036-04-01 | Direct | 44,500 |
Reported balance
After 2026-04-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 44,500 · Balance 44,500 F1: The shares underlying this option vest entirely on April 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying this option vest entirely on April 1, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 8, 2026 01:07 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 44,500 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001104659-26-040565 · tm2611350-1_4seq1.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 44,500 shares Expires 2036-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2027. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 00:26 UTC | Coya Therapeutics, Inc. COYA · Entity 6727 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.65 | $0.00 |
DisclosureSEC source: 0001193125-26-005022 · ownership.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, par value $0.0001 per share · 10,000 shares Expires 2036-01-02 F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant. Read SEC document |
| April 01, 2025 Filed Apr 4, 2025 00:01 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $8.40 | $0.00 |
DisclosureSEC source: 0001104659-25-031828 · tm2511407-4_4seq1.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2035-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2026. Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 02:30 UTC | Coya Therapeutics, Inc. COYA · Entity 6727 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $5.97 | $0.00 |
DisclosureSEC source: 0000950170-25-027252 · ownership.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock, par value $0.0001 per share · 5,000 shares Expires 2035-02-25 F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant. Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 02:30 UTC | Coya Therapeutics, Inc. COYA · Entity 6727 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $5.73 | $0.00 |
DisclosureSEC source: 0000950170-25-001567 · ownership.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock, par value $0.0001 per share · 5,000 shares Expires 2035-01-01 F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 00:00 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $7.73 | $0.00 |
DisclosureSEC source: 0001104659-24-043251 · tm2410652-4_4seq1.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2034-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2025. Read SEC document |
| January 01, 2024 Filed Jan 19, 2024 23:30 UTC | Coya Therapeutics, Inc. COYA · Entity 6727 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $7.41 | $0.00 |
DisclosureSEC source: 0001493152-24-003109 · ownership.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock, par value $0.0001 per share · 5,000 shares Expires 2034-01-01 F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant. Read SEC document |
| August 18, 2023 Filed Aug 22, 2023 00:15 UTC | Coya Therapeutics, Inc. COYA · Entity 6727 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.43 | $0.00 |
DisclosureSEC source: 0000899243-23-018335 · doc4.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, par value $0.0001 per share · 10,000 shares Expires 2033-08-18 Read SEC document |
| April 01, 2023 Filed Apr 5, 2023 00:03 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 37,800 | $0.00 Strike: $17.66 | $0.00 |
DisclosureSEC source: 0001104659-23-041730 · tm2311410-10_4seq1.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,800 Underlying: Common Stock · 37,800 shares Expires 2033-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2024. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:10 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 24,750 | $0.00 Strike: $18.26 | $0.00 |
DisclosureSEC source: 0001104659-22-042755 · tm2211665-11_4seq1.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,750 Underlying: Common Stock · 24,750 shares Expires 2032-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2023. Read SEC document |
| April 01, 2021 Filed Apr 6, 2021 00:13 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 24,750 | $0.00 Strike: $31.58 | $0.00 |
DisclosureSEC source: 0001104659-21-046722 · tm2112099-4_4seq1.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,750 Underlying: Common Stock · 24,750 shares Expires 2031-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2022. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 20:34 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 24,750 | $0.00 Strike: $9.78 | $0.00 |
DisclosureSEC source: 0001104659-20-042508 · a4.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,750 Underlying: Common Stock · 24,750 shares Expires 2030-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2021. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:24 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 13,500 | $0.00 Strike: $15.50 | $0.00 |
DisclosureSEC source: 0001104659-19-019709 · a4.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2029-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2020. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 21:24 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 27,000 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001104659-18-047456 · a4.xml · derivative · entry 1 Weinand Dieter · CIK 0001744419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2028-07-19 F1 · derivative.exercise_date: This option was granted on July 19, 2018 subject to the completion of the Issuer's initial public offering, which closed on July 24, 2018. 25% of the shares underlying this stock option vest on July 19, 2019 and the remainder of the shares underlying this stock option vest in 24 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.